Navigation Links
LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
Date:6/25/2012

LOS ANGELES (June 25, 2012) With summer upon us, more and more people will be heading outdoors and may be putting themselves at risk for various skin conditions which can be caused by continued exposure in the sun. Kevin Bruhn, Ph.D., and Noah Craft, M.D., Ph.D. lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are conducting a study that may help treat the most serious condition caused by prolonged sun exposure: skin cancer. The study will evaluate a novel immune-stimulating cream for treating melanoma, the deadliest form of skin cancer. Initial funding for this project was provided by a grant from Edison International.

Melanoma kills approximately 8,000 Americans each year, and is a growing health problem for low-income populations and ethnic minorities. Drs. Bruhn and Craft believe that melanoma can be successfully combated with treatments that harness the body's immune system. To this end, they have obtained promising results from studies of an immune-stimulating topical cream called Imiquimod. Evidence suggests that Imiquimod might be used to therapeutically treat and perhaps even cure melanomas, especially when used in conjunction with other treatments, such as surgery.

In this study, Drs. Bruhn and Craft are examining how Imiquimod combats melanoma tumors in individual patients at the genetic level. The study will enroll at least 12 untreated melanoma patients from the surrounding communities. The cream will be applied topically to localized skin areas where the tumors exist, and patients will return after two weeks of treatment with the cream to have their malignancies surgically removed. Patients' immunological responses to the treatment will then be assessed on a gene-by-gene level, using cutting-edge sequencing technologies. Drs. Bruhn and Craft are hoping that the knowledge gained from this study will help guide them and other researchers in their efforts to develop personalized immune therapy that saves people's lives.

In addition to the melanoma study, Drs. Bruhn and Craft suggest the following precautions be taken to help prevent skin cancer, which is the most common cancer.

1. It is critical to choose the right sunscreen and use it correctly. Choose at least SPF 30. But keep in mind that higher SPFs don't offer that much more protection. Don't use SPF 60 and think you can apply it half as frequently.

2. Make sure your sunscreen protects against UV-A and UV-B.

3. Don't skimp. Apply very liberally to every part of your body exposed to the sun.

4. Apply sunscreen often, at least every two hours, as it does wear off. You should apply more often if swimming or sweating.

5. Wear a hat, sunglasses, lip balm, and clothing wherever possible, especially between 10 a.m. 4 p.m., when the sun's rays are the strongest.

6. And remember, if you have any suspicious moles or spots especially if they change size, shape, or color, or have irregular edges or different colors, are painful, itchy, or oozing have them looked at by a dermatologist right away.


'/>"/>

Contact: Diana Soltesz
diana@dsmmedia.com
818-592-6747
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
2. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
3. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
4. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
5. LA BioMed receives Grand Challenges Explorations grant
6. Biomedical researchers receive Hartwell Foundation awards
7. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
8. Elinext Leverages Latest QR Code and NFC Technologies in Mobile App Development for Retailers, Manufacturers, Advertisers, and Real Estate Companies
9. MadgeTech, Inc. Develops Temperature Recorder for Harsh Environments
10. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
11. AIUM and AUA guideline development leads to practice accreditation for urologic ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology: